Cargando…

Anticholinergic drugs and risk of dementia: case-control study

OBJECTIVES: To estimate the association between the duration and level of exposure to different classes of anticholinergic drugs and subsequent incident dementia. DESIGN: Case-control study. SETTING: General practices in the UK contributing to the Clinical Practice Research Datalink. PARTICIPANTS: 4...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richardson, Kathryn, Fox, Chris, Maidment, Ian, Steel, Nicholas, Loke, Yoon K, Arthur, Antony, Myint, Phyo K, Grossi, Carlota M, Mattishent, Katharina, Bennett, Kathleen, Campbell, Noll L, Boustani, Malaz, Robinson, Louise, Brayne, Carol, Matthews, Fiona E, Savva, George M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915701/ https://www.ncbi.nlm.nih.gov/pubmed/29695481 http://dx.doi.org/10.1136/bmj.k1315

Ejemplares similares

Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study
por: Grossi, Carlota M., et al.
Publicado: (2019)

History of Benzodiazepine Prescriptions and Risk of Dementia: Possible Bias Due to Prevalent Users and Covariate Measurement Timing in a Nested Case-Control Study
por: Richardson, Kathryn, et al.
Publicado: (2019)

Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II
por: Grossi, Carlota M., et al.
Publicado: (2020)

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis
por: Pieper, Nina T, et al.
Publicado: (2020)

The cognitive impact of anticholinergics: A clinical review
por: Campbell, Noll, et al.
Publicado: (2009)

Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications
por: Soiza, Roy L., et al.
Publicado: (2021)

A novel Artificial Intelligence-based tool to assess anticholinergic burden: a survey
por: Secchi, Agostina, et al.
Publicado: (2022)

Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study
por: Richardson, Kathryn, et al.
Publicado: (2020)

Anticholinergic burden measures and older people’s falls risk: a systematic prognostic review
por: Stewart, Carrie, et al.
Publicado: (2021)

Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer’s disease: A meta-analysis
por: Campbell, Noll, et al.
Publicado: (2008)

Memantine combined with an acetyl cholinesterase inhibitor – hope for the future?
por: Fox, Chris, et al.
Publicado: (2006)

Higher anticholinergic burden from medications is associated with significant increase in markers of inflammation in the EPIC‐Norfolk prospective population‐based cohort study
por: Sanghavi, Ria, et al.
Publicado: (2022)

Deprescribing anticholinergics in primary care older adults: Experience from two models and impact on a continuous measure of exposure
por: Campbell, Noll L., et al.
Publicado: (2022)

The Prognostic Value of Anticholinergic Burden Measures in Relation to Mortality in Older Individuals: A Systematic Review and Meta-Analysis
por: Graves-Morris, Katherine, et al.
Publicado: (2020)

Prognostic Tools for Early Mortality in Hemorrhagic Stroke: Systematic Review and Meta-Analysis
por: Mattishent, Katharina, et al.
Publicado: (2015)

Efficacy of Memantine for Agitation in Alzheimer’s Dementia: A Randomised Double-Blind Placebo Controlled Trial
por: Fox, Chris, et al.
Publicado: (2012)

Protocol for a feasibility randomised controlled trial of Screening and Enhanced Risk management for Vascular Event-related Decline in Memory (SERVED Memory)
por: Myint, Phyo Kyaw, et al.
Publicado: (2017)

Anticholinergic drugs and risk of dementia: Time for action?
por: Bell, Brian, et al.
Publicado: (2021)

Behavioural and psychological symptoms in the older population without dementia - relationship with socio-demographics, health and cognition
por: van der Linde, Rianne, et al.
Publicado: (2010)

The challenge of supporting care for dementia in primary care
por: Boustani, Malaz, et al.
Publicado: (2007)

The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study
por: Matthews, Fiona, et al.
Publicado: (2005)

Correction: The Incidence of Dementia in England and Wales: Findings from the Five Identical Sites of the MRC CFA Study
por: Matthews, Fiona, et al.
Publicado: (2005)

Anticholinergic burden in older adult inpatients: patterns from admission to discharge and associations with hospital outcomes
por: Herrero-Zazo, Maria, et al.
Publicado: (2021)

A commentary on studies presenting projections of the future prevalence of dementia
por: Norton, Sam, et al.
Publicado: (2013)

Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review
por: Stewart, Carrie, et al.
Publicado: (2021)

Prevalence of dementia in East Asia: a synthetic review of time trends
por: Wu, Yu-Tzu, et al.
Publicado: (2015)

Meta-Analysis: Association Between Hypoglycemia and Serious Adverse Events in Older Patients Treated With Glucose-Lowering Agents
por: Mattishent, Katharina, et al.
Publicado: (2021)

Characterization of hepatic enzyme activity in older adults with dementia: potential impact on personalizing pharmacotherapy
por: Campbell, Noll L, et al.
Publicado: (2015)

Potential Value of Impaired Cognition in Stroke Prediction: A U.K. Population‐Based Study
por: Stephan, Blossom C. M., et al.
Publicado: (2017)

Grouping of behavioural and psychological symptoms of dementia†
por: van der Linde, Rianne M, et al.
Publicado: (2014)

A Predictive In Vitro Model of the Impact of Drugs with Anticholinergic Properties on Human Neuronal and Astrocytic Systems
por: Woehrling, Elizabeth K., et al.
Publicado: (2015)

Occurrence of medical co-morbidity in mild cognitive impairment: implications for generalisation of MCI research
por: Stephan, Blossom C. M., et al.
Publicado: (2011)

Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
por: Coupland, Carol A. C., et al.
Publicado: (2019)

Anticholinergic drugs and risk of dementia: case-control study
Publicado: (2019)

Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2022)

Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2021)

Anticholinergic medication exposure predicts poor physical capability: Findings from a large prospective cohort study in England
por: Yrjana, Kaisa R., et al.
Publicado: (2020)

A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: results of the Cognitive Function and Ageing Study I and II
por: Matthews, Fiona E, et al.
Publicado: (2013)

Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale
por: Suh, Yewon, et al.
Publicado: (2020)

A gero-informatics tool to enhance the care of hospitalized older adults with cognitive impairment
por: Boustani, Malaz, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_k129cp3ftsi5apppab3bgjgtc5